These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 33936506)
1. A Descriptive Study of HIV Patients Highly Adherent to Antiretroviral. Williams N; Mayer C; Huser V AMIA Annu Symp Proc; 2020; 2020():1295-1304. PubMed ID: 33936506 [TBL] [Abstract][Full Text] [Related]
2. Geographic variation in medication adherence in commercial and Medicare part D populations. Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077 [TBL] [Abstract][Full Text] [Related]
3. Do Medicare Beneficiaries Living With HIV/AIDS Choose Prescription Drug Plans That Minimize Their Total Spending? Desmond KA; Rice TH; Leibowitz AA Inquiry; 2017 Jan; 54():46958017734032. PubMed ID: 28990452 [TBL] [Abstract][Full Text] [Related]
4. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina. Sengupta S N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558 [TBL] [Abstract][Full Text] [Related]
5. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement. Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892 [TBL] [Abstract][Full Text] [Related]
7. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D. Blumberg DM; Prager AJ; Liebmann JM JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes. Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119 [TBL] [Abstract][Full Text] [Related]
9. Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015. Watanabe JH; Chau DL; Hirsch JD J Am Geriatr Soc; 2018 Aug; 66(8):1621-1624. PubMed ID: 29972589 [TBL] [Abstract][Full Text] [Related]
10. Healthcare costs associated with antiretroviral adherence among medicaid patients. Pruitt Z; Robst J; Langland-Orban B; Brooks RG Appl Health Econ Health Policy; 2015 Feb; 13(1):69-80. PubMed ID: 25403718 [TBL] [Abstract][Full Text] [Related]
11. Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability. Rogan EL; Ranson CA; Mori TK; Park SK; Lam HM; Legaspi JF; Tran LK; Cameros CJM; Blackburn AN; Lee ST; Valle-Oseguera CS; Pham CN; Woelfel JA; Patel RA Intellect Dev Disabil; 2019 Jun; 57(3):234-241. PubMed ID: 31120407 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs. Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379 [TBL] [Abstract][Full Text] [Related]
13. The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care. Gardner EM; Maravi ME; Rietmeijer C; Davidson AJ; Burman WJ Appl Health Econ Health Policy; 2008; 6(2-3):145-55. PubMed ID: 19231907 [TBL] [Abstract][Full Text] [Related]
14. Nonadherence to Any Prescribed Medication Due to Costs Among Adults with HIV Infection - United States, 2016-2017. Beer L; Tie Y; Weiser J; Shouse RL MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(49):1129-1133. PubMed ID: 31830009 [TBL] [Abstract][Full Text] [Related]
15. Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon". Doshi JA; Li P; Pettit AR; Dougherty JS; Flint A; Ladage VP Am J Manag Care; 2017 Mar; 23(3 Suppl):S39-S45. PubMed ID: 29648739 [TBL] [Abstract][Full Text] [Related]
16. Mind the Gap: Why Closing the Doughnut Hole Is Insufficient for Increasing Medicare Beneficiary Access to Oral Chemotherapy. Dusetzina SB; Keating NL J Clin Oncol; 2016 Feb; 34(4):375-80. PubMed ID: 26644524 [TBL] [Abstract][Full Text] [Related]
17. Cost minimization of medicare part D prescription drug plan expenditures. Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958 [TBL] [Abstract][Full Text] [Related]
18. Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'. Patel RA; Vo KA; Chu T; Wang K; Lu S; Woelfel JA; Carr-Lopez SM; Galal SM J Am Pharm Assoc (2003); 2014; 54(6):604-9. PubMed ID: 25379981 [TBL] [Abstract][Full Text] [Related]
19. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
20. The growing cohort of seniors with HIV/AIDS: changing the scope of Medicare Part D. Flaer PJ; Benjamin PL; Malow RM; Morisky DE; Parkash J AIDS Care; 2010 Jul; 22(7):903-8. PubMed ID: 20635255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]